Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) investors concerning the Company and its officers' possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Dentsply investigation page on our website at www.glancylaw.com/case/dentsply-sirona-inc. On August 9, 2017, the Company disclosed second quarter 2017 earnings that fell below expectations, as well as a SEC investigation, "concerning the Company's accounting and disclosures, including its accounting and disclosures relating to transactions with a significant distributor of the Company." On this news, the Company's stock price fell sharply, $5.18 per share, or 8.44%, to close at $56.23 per share on August 9, 2017. If you purchased Dentsply securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to firstname.lastname@example.org, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.